Gargiulo & Co. To Host Premier Event for FONAR Corporation.

Business Editors/ Health&Medical Writers

JERSEY CITY, N.J.--(BW HealthWire)--Nov. 17, 2000

Gargiulo & Co., a registered investment advisor in the State of New York, will host a premier event for the investment community at the Radiological Society of North America (RSNA) on Monday November 27, 2000 on behalf of FONAR Corporation (NASDAQ-FONR). It will be held at McCormick Place, Hall A, booth #3546 at 3:00 PM CST.

A presentation will be given by Raymond Damadian, M.D., president and chairman, about Indomitable(TM), its new positional, stand-up MRI, and its other MRI scanners known as the 'FONAR Seven'. The Company recently was granted permission by the FDA to market Indomitable(TM).

Generio Gargiulo, president and director of research for Gargiulo & Co., has been researching FONAR since April of 1999. On March 8, 2000, they finished an in-depth technology report on FONAR. In November of 1999, Mr. Gargiulo attended the last meeting of RSNA which is considered to be the largest medical show in the world and the premiere marketing event for manufacturers of diagnostic imaging equipment.

Mr. Gargiulo says "The company promises to have an exciting high-tech exhibit and a highlight of the exhibit will be Indomitable(TM)." He noted Dr. Damadian's recent statement: "Approximately 50% of all MRIs performed today are of the spine. Often, symptoms are experienced or they are most intense only when the patient is in his normal functioning position - upright. It is common sense to want to see exactly what is going on when the patient is in the very position in which his symptoms occur. The Upright MRI(TM) or (Stand-Up MRI(TM)) will permit the physician to make his diagnosis more complete, allow him to be better informed regarding the patient's prospects for surgery and determine which specific surgical procedure might be best for him. Only Indomitable(TM) can meet this need for upright visualization of the body's interior."

Analysts, brokers and Institutional representatives are welcome to attend. Please RSVP to Amelia Irizarry Voorsanger at 201-432-2522 or e:mail her at [e-mail].

This release contains forward-looking statements pursuant to the Private Securities Litigation Act of 1995. This information may involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. This security may involve a high degree of risk. Moreover, there may exist a conflict of interest, since the company pays G. Gargiulo & Co. fees for its evaluation services. G. Gargiulo & Co. may continue to provide research and/or consulting services to the Subject Company.